Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02932007 · ClinicalTrials.gov registry record · Phase 2

Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

A Phase 2 study of Atrial Fibrillation, sponsored by University of South Florida.

Recruiting
Registry status
Phase 2
Development phase
40
Enrollment target
1
Study location

NCT02932007 is a Phase 2 study of Atrial Fibrillation that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 40 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02932007, a Phase 2 study of Atrial Fibrillation, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
Phase 2
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.

Conditions Studied

Atrial Fibrillation

Interventions

  • DRUG Chloroquine Phosphate

Study Locations (1)

Florida

  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-03-28
Est. Completion 2020-09
Phase Phase 2

Sponsor

University of South Florida

252 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02932007

The ClinicalTrials.gov registry entry for NCT02932007 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (99% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Chloroquine Phosphate is the first listed.

NCT02932007 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02932007 about?

NCT02932007 is a clinical study titled "Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study". The goal of this pilot study is to explore the efficacy of chloroquine in terminating persistent AF and assess its potential role as a pharmacological cardioversion agent for the management of AF.

What is the current status of trial NCT02932007?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2017-03-28. Estimated completion is 2020-09.

What conditions does trial NCT02932007 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT02932007?

The interventions under investigation include: Chloroquine Phosphate (DRUG).

Who is sponsoring clinical trial NCT02932007?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02932007 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.